Recent Posts From DIV-Net Members

IFON No Longer Cheaper Than An iPhone

Just over a year ago, InfoSonics was discussed on this site as a potential value investment. The stock promptly rose in the ensuing couple of months, but then got absolutely annihilated in the 3rd quarter of last year when double-dip and sovereign default fears reigned over the market. The stock has now bounced back, and while it may still be undervalued, value investors may want to take some off the table in order to pursue today's best opportunities.


Continue Reading »

Stock Analysis: Chevron Corporation (CVX)

Linked here is a detailed quantitative analysis of Chevron Corporation (CVX). Below are some highlights from the above linked analysis:

Company Description: Chevron Corporation is a global integrated oil company (formerly ChevronTexaco) with interests in exploration, production, refining and marketing, and petrochemicals.

Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:

1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number

CVX is trading at a discount to 3.) and 4.) above. The stock is trading at a 16.5% premium to its calculated fair value of $91.53. CVX did not earn any Stars in this section.

Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:

1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%

CVX earned two Stars in this section for 2.) and 3.) above. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. CVX earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1912 and has increased its dividend payments for 25 consecutive years.

Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:

1. NPV MMA Diff.
2. Years to > MMA

The NPV MMA Diff. of the $487 is below the $1,000 target I look for in a stock that has increased dividends as long as CVX has. If CVX grows its dividend at 4.9% per year, it will take 1 years to equal a MMA yielding an estimated 20-year average rate of 3.1%. CVX earned a check for the Key Metric 'Years to >MMA' since its 1 years is less than the 5 year target.

Memberships and Peers: CVX is a member of the S&P 500 a member of the Broad Dividend Achievers™ Index. The company's peer group includes: BP plc (BP) with a 4.2% yield, Exxon Mobil Corporation (XOM) with a 2.2% yield and ConocoPhillips (COP) with a 3.6% yield.

Conclusion: CVX did not earn any Stars in the Fair Value section, earned two Stars in the Dividend Analytical Data section and did not earn any Stars in the Dividend Income vs. MMA section for a total of two Stars. This quantitatively ranks CVX as a 2-Star Weak stock.

Using my D4L-PreScreen.xls model, I determined the share price would need to decrease to $83.08 before CVX's NPV MMA Differential increased to the $1,000 minimum that I look for in a stock with 25 years of consecutive dividend increases. At that price the stock would yield 3.9%.

Resetting the D4L-PreScreen.xls model and solving for the dividend growth rate needed to generate the target $1,000 NPV MMA Differential, the calculated rate is 7.3%. This dividend growth rate is well above the 4.9% used in this analysis, thus providing a margin of safety. CVX has a risk rating of 1.50 which classifies it as a Low risk stock.

CVX is reducing its refining footprint and focusing on large, long-lived upstream projects with higher margins and growth potential. As with other large multinationals, the company is finding it increasingly difficult to add reserves. Much of the remaining easily accessible reserves are owned by governments and national oil companies. As a result, CVX is focusing more on deepwater exploration.

The company's financials are generally good. Several metrics are just outside my desired range. Though its free cash flow payout is below my 60% maximum, CVX had one year of negative free cash flow during the last 10 which prevents it from earning a star. Also, it is trading at a premium to my $91.53 calculated fair value. The stock has treated me well in the past, but for now, I plan to wait on a better entry point.

Disclaimer: Material presented here is for informational purposes only. The above quantitative stock analysis, including the Star rating, is mechanically calculated and is based on historical information. The analysis assumes the stock will perform in the future as it has in the past. This is generally never true. Before buying or selling any stock you should do your own research and reach your own conclusion. See my Disclaimer for more information.

Full Disclosure: At the time of this writing, I was long in CVX (2.1% of my Dividend Growth Portfolio). See a list of all my dividend growth holdings here.

Related Articles:
- Exxon Mobil Corporation (XOM) Dividend Stock Analysis
- AT&T Inc. (T) Dividend Stock Analysis
- Lockheed Martin Corp. (LMT) Dividend Stock Analysis
- The 2012 Dividend Achievers
- More Stock Analysis

This article was written by Dividends4Life. If you enjoyed this article, please subscribe to my feed [RSS], or have future articles emailed to you [Email] or follow me on Twitter [Twitter].


Continue Reading »

Weekend Reading Links - February 26, 2012

For your weekend reading pleasure, the articles listed below contain some of the best dividend and value investing insights found on the web. They were written by various members of the Dividend Investing and Value Network over the past week:

Articles From DIV-Net Members

There are some really good articles here, please take time and read a few of them.


Continue Reading »

Kimberly-Clark Corporation Stock Analysis

Kimberly-Clark Corporation (KMB), together with its subsidiaries, engages in the manufacture and marketing of health care products worldwide. The company operates in four segments: Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care. This dividend aristocrat has paid uninterrupted dividends on its common stock since 1935 and increased payments to common shareholders every for 39 consecutive years.

The company’s last dividend increase was in April 2011 when the Board of Directors approved a 6% increase to 70 cents/share. Kimberly-Clark’s largest competitors include Procter & Gamble (PG), Colgate-Palmolive (CL) and Clorox (CLX).

Over the past decade this dividend growth stock has delivered an annualized total return of 5.70% to its shareholders.
The company has managed to deliver an 4.40% annual increase in EPS since 2001. Analysts expect Kimberly-Clark to earn $4.83 per share in 2011 and $5.25 per share in 2012. In comparison Kimberly-Clark earned $4.45 /share in 2010. The company has managed to consistently repurchase 3.10% of its outstanding shares on average in each year over the past decade.

The company’s return on equity has mostly remained above 20% over the past decade, with a few exceptions in 2001 and 2006. Rather than focus on absolute values for this indicator, I generally want to see at least a stable return on equity over time.
The annual dividend payment has increased by 9.70% per year since 2001, which is higher than to the growth in EPS.

A 10% growth in distributions translates into the dividend payment doubling every seven years. If we look at historical data, going as far back as 1974 we see that Kimberly-Clark has actually managed to double its dividend every seven and a half years on average.

The dividend payout ratio has increased from 37% in 2001 to 59% in 2010. A lower payout is always a plus, since it leaves room for consistent dividend growth minimizing the impact of short-term fluctuations in earnings.
Currently Kimberly-Clark is attractively valued at 17.80 times earnings, has a sustainable dividend payout and yields 3.90%.

Full Disclosure: Long KMB, CL, CLX, PG

Relevant Articles:



This article was written by Dividend Growth Investor. If you enjoyed this article, please subscribe to my feed [RSS], or have future articles emailed to you [Email] or follow me on Twitter [Twitter].


Continue Reading »

Still Waiting For That Correction

I wrote last month of my hopes for a correction, yet none has come. I think that simply proves that the more you try to predict the market, the more you'll likely be frustrated. There are many, many examples out there of studies showing professional stock pickers and market timers handily under-performing the general market. That's why I continue to stick to my plan of investing in quality and attractive dividend growth stocks every single month, no matter what the market is doing.

The Dow Jones Industrial Average is up 5.9% YTD, and we're not even two months into the year. The DJIA recently eclipsed 13,000 points, which is a sentimental number for many investors. I don't hold much credence or confidence in round numbers like that, but it does show the confidence in the hearts of investors. I think some of this confidence is a bit of a self-fulfilling prophecy as investors continue to buy into a rising market. That is a bit troubling, as the fall could be harder and faster than the rise as the self-fulfilling prophecy comes full circle. We'll see.

Next week the DJIA could rise 200 points, it could fall 200 points or it could stay static. The point is that nobody knows. The quicker you realize this and ignore the noise, the faster you'll be better off for it. You're simply a cork floating in a giant sea. You do not have power to move the sea, but you do have the power to buy when you're at the bottom of a wave. Buy on the dips.

For me, I'll continue to find the best values that Mr. Market presents me. If I truly find none, then I'll hold my cash and wait for an opportunity to come to me. I don't chase stocks, but I also don't enjoy holding on to large amounts of cash. Cash is a terrible investment historically.

What about you? Are you a cork floating in the sea, buying on the dips?

Thanks for reading.

This article was written by Dividend Mantra. If you enjoyed this article, please consider subscribing to my feed.


Continue Reading »

Stock Analysis: Target Corporation (TGT)

Linked here is a detailed quantitative analysis of Target Corporation (TGT). Below are some highlights from the above linked analysis:

Company Description: Target Corp. operates about 1,500 Target and 250 SuperTarget general merchandise stores across the U.S.

Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:

1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number

TGT is trading at a discount to 1.) and 3.) above. The stock is trading at a 22.3% discount to its calculated fair value of $67.48. TGT earned a Star in this section since it is trading at a fair value.

Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:

1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%

TGT earned one Star in this section for 3.) above. TGT earned a Star for having an acceptable score in at least two of the four Key Metrics measured. Rolling 4-yr Div. > 15% means that dividends grew on average in excess of 15% for each consecutive 4 year period over the last 10 years (2002-2005, 2003-2006, 2004-2007, etc.) I consider this a key metric since dividends will double every 5 years if they grow by 15%. The company has paid a cash dividend to shareholders every year since 1965 and has increased its dividend payments for 44 consecutive years.

Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:

1. NPV MMA Diff.
2. Years to > MMA

TGT earned a Star in this section for its NPV MMA Diff. of the $6,392. This amount is in excess of the $500 target I look for in a stock that has increased dividends as long as TGT has. If TGT grows its dividend at 17.4% per year, it will take 3 years to equal a MMA yielding an estimated 20-year average rate of 3.1%. TGT earned a check for the Key Metric 'Years to >MMA' since its 3 years is less than the 5 year target.

Memberships and Peers: TGT is a member of the S&P 500, a Dividend Aristocrat and a member of the Broad Dividend Achievers™ Index and a Dividend Champion. The company's peer group includes: Wal-Mart Stores Inc. (WMT) with a 2.4% yield, Costco Wholesale Corporation (COST) with a 1.1% yield and Family Dollar Stores (FDO) with a 1.5% yield.

Conclusion: TGT earned one Star in the Fair Value section, earned one Star in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of three Stars. This quantitatively ranks TGT as a 3-Star Hold stock.

Using my D4L-PreScreen.xls model, I determined the share price would need to increase to $139.21 before TGT's NPV MMA Differential decreased to the $500 minimum that I look for in a stock with 44 years of consecutive dividend increases. At that price the stock would yield 0.8%.

Resetting the D4L-PreScreen.xls model and solving for the dividend growth rate needed to generate the target $500 NPV MMA Differential, the calculated rate is 8.6%. This dividend growth rate is well below the 17.4% used in this analysis, thus providing a significant margin of safety. TGT has a risk rating of 1.75 which classifies it as a Medium risk stock.

TGT has produced fairly consistent earnings and cash flows over the last decade. However, future returns will likely be lower as the company focuses more assets to its lower-return food business (PFresh). The Canadian market should provide an attractive incremental growth opportunity for the company, but in the near-term this expansion will have a negative impact on cash flows. Management intends to sell the credit card receivables business.

The company's double-digit dividend growth rate since 2005 has made it a stock to watch. Although it is trading below my fair value price of $67.48, I am not ready to buy due to the above-mentioned concerns and a higher level of debt than I prefer. For now I will continue to watch from the sidelines.

Disclaimer: Material presented here is for informational purposes only. The above quantitative stock analysis, including the Star rating, is mechanically calculated and is based on historical information. The analysis assumes the stock will perform in the future as it has in the past. This is generally never true. Before buying or selling any stock you should do your own research and reach your own conclusion. See my Disclaimer for more information.

Full Disclosure: At the time of this writing, I held no position in TGT (0.0% of my Income Portfolio) and was long in WMT. See a list of all my dividend growth holdings here.

Related Articles:
- Lockheed Martin Corp. (LMT) Dividend Stock Analysis
- The 2012 Dividend Achievers
- Leggett & Platt, Inc. (LEG) Dividend Stock Analysis
- 3M Company (MMM) Dividend Stock Analysis
- More Stock Analysis

This article was written by Dividends4Life. If you enjoyed this article, please subscribe to my feed [RSS], or have future articles emailed to you [Email] or follow me on Twitter [Twitter].


Continue Reading »

Weekend Reading Links - February 18, 2012

For your weekend reading pleasure, the articles listed below contain some of the best dividend and value investing insights found on the web. They were written by various members of the Dividend Investing and Value Network over the past week:

Articles From DIV-Net Members

There are some really good articles here, please take time and read a few of them.


Continue Reading »

PepsiCo Stock Analysis

PepsiCo, Inc. (PEP) manufactures, markets, and sells various foods, snacks, and carbonated and non-carbonated beverages worldwide. The company operates in four divisions: PepsiCo Americas Foods (PAF), PepsiCo Americas Beverages (PAB), PepsiCo Europe, and PepsiCo Asia, Middle East and Africa (AMEA). The company is a dividend aristocrat which has increased distributions for 38 years in a row. The most recent dividend increase was in May 2011, when the Board of Directors approved a 7.30% increase in the quarterly dividend to 51.50 cents/share. PepsiCo’s largest competitors include Coca Cola (KO) and Dr Pepper Snapple Group (DPS).

Over the past decade this dividend growth stock has delivered an annualized total return of 5.50% to its loyal shareholders.

The company has managed to deliver an average increase in EPS of 12.10% per year since 2001. Analysts expect PepsiCo to earn $4.41 per share in 2011 and $4.65 per share in 2012. This would be a nice increase from the $3.91/share the company earned in 2010. Over the past decade, PepsiCo has consistently managed to repurchase 1% of its outstanding shares every year, on average.

The company has a high return on equity, which has remained above 30%, with the exception of a brief decrease in 2005. Rather than focus on absolute values for this indicator, I generally want to see at least a stable return on equity over time.

The annual dividend payment has increased by 14% per year since 2001. A 14% growth in distributions translates into the dividend payment doubling every five years. If we look at historical data, going as far back as 1978, we see that PepsiCo has actually managed to double its dividend every six and a half years on average.

Over the past decade the dividend payout ratio has remained above 50% briefly in 2008. A lower payout is always a plus, since it leaves room for consistent dividend growth minimizing the impact of short-term fluctuations in earnings.

Currently, PepsiCo is attractively valued at 16.50 times earnings, yields 2.90% and has a sustainable dividend payout. In comparison Coca Cola (KO) yields 2.70% and trades at a P/E of 20. I find PepsiCo to be a better value than Coca Cola in the current environment. Investors who subtract the one-time accounting gains from Coke's EPS would find Coca Cola overvalued relative to PepsiCo. As a result, I would give major preference to PepsiCo shares over Coca Cola.

Full Disclosure: Long PEP and KO

Relevant Articles:



This article was written by Dividend Growth Investor. If you enjoyed this article, please subscribe to my feed [RSS], or have future articles emailed to you [Email] or follow me on Twitter [Twitter].


Continue Reading »

Stick To Your Plan

The market has been on a tear to start 2012. The S&P is up 6.81% YTD, and it's showing little signs of slowing. This is a good thing or a bad thing, depending on your investment strategy. If you're a value-oriented dividend growth investor like myself, a market on fire can dim the prospects of finding a good value with which to put your capital to work.

There's a lot of talk about a forthcoming pullback in the market, due to the strong performance out of the gate. I agree that there is probably a pullback on the horizon, but when will it come and how large will it be? I lack the ability to answer these questions so I do one thing: I stick to my plan.

I have a plan. My plan involves saving a high percentage of my net income (over 60%) and using that excess capital to invest in attractive dividend growth stocks month after month after month. The market will go up and down by many percentage points during the course of this plan, which is likely going to be more than a decade long. After I'm done with the plan, I'll have a large portfolio filled with dividend growth stocks that pay out dividends in amounts that exceed my monthly expenses, and continue to raise those dividends at rates that exceed inflation. This way, even as my expenses go up over time my income rises even faster.

I'm showing my dedication to that plan. Even though the market is strong and many are awaiting an eventual pullback I entered the fray and recently added to my positions with PEP and NSC. The market could drop like a rock tomorrow, and you know what? I'll just buy some more. That's me sticking to my plan.

What's your plan? Are you sticking to it?

Thanks for reading.

This article was written by Dividend Mantra. If you enjoyed this article, please consider subscribing to my feed.


Continue Reading »

Advice From Schloss

Walter Schloss had a superb 45-year investing record. Want to know his advice for beating the market? Here are his 16 Golden Rules, as summarized by Business Insider:


Continue Reading »

Stock Analysis: Emerson Electric Co. (EMR)

Linked here is a detailed quantitative analysis of Emerson Electric Co. (EMR). Below are some highlights from the above linked analysis:

Company Description: Emerson Electric Co. designs and supplies product technology, and delivers engineering services and solutions to a wide range of industrial, commercial, and consumer markets around the world.

Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:

1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number

EMR is trading at a discount to only 3.) above. Since EMR's tangible book value is not meaningful, a Graham number can not be calculated. The stock is trading at a 27.3% premium to its calculated fair value of $41.41. EMR did not earn any Stars in this section.

Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:

1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%

EMR earned three Stars in this section for 1.), 2.) and 3.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%.

The company earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1947 and has increased its dividend payments for 56 consecutive years.

Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:

1. NPV MMA Diff.
2. Years to > MMA

EMR earned a Star in this section for its NPV MMA Diff. of the $774. This amount is in excess of the $500 target I look for in a stock that has increased dividends as long as EMR has. If EMR grows its dividend at 6.4% per year, it will take 1 years to equal a MMA yielding an estimated 20-year average rate of 3.1%. EMR earned a check for the Key Metric 'Years to >MMA' since its 1 years is less than the 5 year target.

Memberships and Peers: EMR is a member of the S&P 500, a Dividend Aristocrat and a member of the Broad Dividend Achievers™ Index and a Dividend Champion. The company's peer group includes: Espey Manufacturing & Electronics Corp. (ESP) with a 3.8% yield, Cooper Industries plc (CBE) with a 1.9% yield and Regal Beloit Corporation (RBC) with a 1.2% yield.

Conclusion: EMR did not earn any Stars in the Fair Value section, earned three Stars in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of four Stars. This quantitatively ranks EMR as a 4-Star Strong stock.

Using my D4L-PreScreen.xls model, I determined the share price would need to increase to $60.96 before EMR's NPV MMA Differential decreased to the $500 minimum that I look for in a stock with 56 years of consecutive dividend increases. At that price the stock would yield 2.6%.

Resetting the D4L-PreScreen.xls model and solving for the dividend growth rate needed to generate the target $500 NPV MMA Differential, the calculated rate is 4.9%. This dividend growth rate is lower than the 6.4% used in this analysis, thus providing a margin of safety. EMR has a risk rating of 1.50 which classifies it as a Low risk stock.

EMR holds a broad portfolio of industrial businesses with a strong competitive positions. The company has a reputation for providing consistent returns to its investors. It is EMR is well positioned to benefit from any strengthening in the global economy, especially from spending on infrastructure.

EMR’s advantages include globally branded platforms, new products in the pipeline, a strong balance sheet and a low free cash flow payout. The stock is currently trading above my calculated fair value price of $41.41. I will wait for opportune dips before adding to my position.

Disclaimer: Material presented here is for informational purposes only. The above quantitative stock analysis, including the Star rating, is mechanically calculated and is based on historical information. The analysis assumes the stock will perform in the future as it has in the past. This is generally never true. Before buying or selling any stock you should do your own research and reach your own conclusion. See my Disclaimer for more information.

Full Disclosure: At the time of this writing, I was long in EMR (2.6% of my Dividend Growth Portfolio). See a list of all my dividend growth holdings here.

Related Articles:
- Leggett & Platt, Inc. (LEG) Dividend Stock Analysis
- 3M Company (MMM) Dividend Stock Analysis
- Digital Realty Trust, Inc. (DLR) Dividend Stock Analysis
- Verizon Communications Inc. (VZ) Dividend Stock Analysis
- More Stock Analysis

This article was written by Dividends4Life. If you enjoyed this article, please subscribe to my feed [RSS], or have future articles emailed to you [Email] or follow me on Twitter [Twitter].


Continue Reading »

Weekend Reading Links - February 12, 2012

For your weekend reading pleasure, the articles listed below contain some of the best dividend and value investing insights found on the web. They were written by various members of the Dividend Investing and Value Network over the past week:

Articles From DIV-Net Members

There are some really good articles here, please take time and read a few of them.


Continue Reading »

Abbott Stock Analysis

Abbott Laboratories (ABT) engages in the discovery, development, manufacture, and sale of health care products worldwide. It operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The company is a dividend aristocrat which has increased distributions for 39 years in a row. The most recent dividend increase was in February 2011, when the Board of Directors approved a 9.10% increase in the quarterly dividend to 48 cents/share. Abbott’s largest competitors include Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY) and Sanofi (SNY).

Over the past decade this dividend growth stock has delivered an annualized total return of 3.50% to its loyal shareholders.

The company has managed to deliver an average increase in EPS of 12.90% per year since 2001. Analysts expect Abbott Laboratories to earn $4.65 per share in 2011 and $5.03 per share in 2012. This would be a nice increase from the $2.96/share the company earned in 2010.

The company has a high return on equity, which has remained above 20%, with the exception of a brief decrease in 2001 and 2006. Rather than focus on absolute values for this indicator, I generally want to see at least a stable return on equity over time.
The annual dividend payment has increased by 8.60% per year since 2001. A 9% growth in distributions translates into the dividend payment doubling every eight years. If we look at historical data, going as far back as 1986, we see that Abbott Laboratories has actually managed to double its dividend every six years on average.
Over the past decade the dividend payout ratio has largely remained above 50%. This indicator has been closer to 50% over the past few years. A lower payout is always a plus, since it leaves room for consistent dividend growth minimizing the impact of short-term fluctuations in earnings.
Currently, Abbott Laboratories is attractively valued at 15.60 times earnings, yields 3.80% and has a sustainable dividend payout. In comparison Johnson & Johnson (JNJ) yields 3.60% and trades at a P/E of 12.70. I would continue monitoring Abbott Labs and will consider adding to a position in the stock on dips.

Full Disclosure: Long ABT

Relevant Articles:



This article was written by Dividend Growth Investor. If you enjoyed this article, please subscribe to my feed [RSS], or have future articles emailed to you [Email] or follow me on Twitter [Twitter].


Continue Reading »

Diebold Raises Dividend for 59th Year In A Row

Diebold Incorporated (DBD), a manufacturer, supplier and servicing company for ATM's and security systems has recently declared a raise in the quarterly dividend for the 59th year in a row. The quarterly dividend is now $0.28.5 cents per share, up from the previous quarterly dividend of $0.28 per share. This new dividend amounts to $1.14 per share on an annual basis, which is an increase of 1.8 percent from the previous annual dividend payout.

Per Morningstar:

Diebold builds, sells, and services ATMs and security products and systems. The majority of Diebold's revenue comes from the sale and service of ATMs, split about equally between the two. The firm also provides security solutions such as access control products, video surveillance, and communications systems. The company derives roughly half of its revenue from overseas. 

Diebold has one of the longest known records of raising its dividend. Usually, a company that has raised its dividend for 59 years in a row is a prime candidate for my stock portfolio. Unfortunately, this company's future prospects concern me. Earnings and revenue are on the severe decline and the payout ratio is sky high. I admire the company for continuing to raise the dividend, even if it's a token amount, but I'll be putting my capital to work in other places. DBD currently does not have a P/E ratio due to negative earnings and they sport a fairly high debt/equity ratio of 0.8. I don't see a large economic moat or competitive advantage here, and I also don't see a lot of growth in its business going forward.

Full Disclosure: None

Thanks for reading.

This article was written by Dividend Mantra. If you enjoyed this article, please consider subscribing to my feed.


Continue Reading »

Amtech Trades Like It's Broke

You probably won't find a lot of value investors in the solar industry. As a relatively nascent industry, it hasn't yet proved its economic viability. Moreover, that viability is based on the prices of substitutes (e.g. natural gas, wind power etc.) and perhaps the support of the agents of taxpayers (i.e. politicians). Finally, there is a commodity-like element to this industry, as companies fight to provide relatively undifferentiated products to customers only interested in price.

This introduces a ton of risk into the equation for anyone trying to value a solar stock to any reasonable degree of certainty. But sometimes, could a balance sheet be so pristine that it trumps many of the downside risks, leaving only the upside potential of this volatile industry to the investor?


Continue Reading »

Stock Analysis: AT&T Inc. (T)

Linked here is a detailed quantitative analysis of AT&T Inc. (T). Below are some highlights from the above linked analysis:

Company Description: AT&T Inc. provides telephone and broadband service and holds full ownership of AT&T Mobility (formerly Cingular Wireless). Plans to acquire T Mobile USA were recently scrapped.

Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:

1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number

T is trading at a premium to all four valuations above. Since T's tangible book value is not meaningful, a Graham number can not be calculated. The stock is trading at a 36.3% premium to its calculated fair value of $21.61. T did not earn any Stars in this section.

Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:

1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%

T earned two Stars in this section for 2.) and 3.) above. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. T earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1984 and has increased its dividend payments for 28 consecutive years.

Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:

1. NPV MMA Diff.
2. Years to > MMA

T earned a Star in this section for its NPV MMA Diff. of the $1,509. This amount is in excess of the $700 target I look for in a stock that has increased dividends as long as T has. The stock's current yield of 5.84% exceeds the 3.1% estimated 20-year average MMA rate.

Memberships and Peers: T is a member of the S&P 500, a Dividend Aristocrat and a member of the Broad Dividend Achievers™ Index and a Dividend Champion. The company's peer group includes: CenturyLink, Inc. (CTL) with a 7.7% yield, Sprint Nextel Corp. (S) with a 0.0% yield and Verizon Communications Inc. (VZ) with a 5.3% yield.

Conclusion: T did not earn any Stars in the Fair Value section, earned two Stars in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of three Stars. This quantitatively ranks T as a 3-Star Hold stock.

Using my D4L-PreScreen.xls model, I determined the share price would need to increase to $39.60 before T's NPV MMA Differential decreased to the $700 minimum that I look for in a stock with 28 years of consecutive dividend increases. At that price the stock would yield 4.3%.

Resetting the D4L-PreScreen.xls model and solving for the dividend growth rate needed to generate the target $700 NPV MMA Differential, the calculated rate is -0.9%. This dividend growth rate is lower than the 2.4% used in this analysis, thus providing a margin of safety. T has a risk rating of 2.00 which classifies it as a Medium risk stock.

T is in a strong competitive position. Such a strong competitive position, that it abandoned it bid to purchase T-Mobile due to concerns that regulatory approval would be hard to come by. The gains in consumer wireless and broadband should continue to outpace losses wireline customers. It should generate good operating margins in 2012.

The company has a strong balance sheet and exercises power over many of its suppliers. A concern is its Free Cash Flow payout has crept up to 68%, which is at the higher end of its 10 year range. It is currently trading well above my calculated fair value price of $21.61, so for now I will wait for a more favorable time to add to my position.

Disclaimer: Material presented here is for informational purposes only. The above quantitative stock analysis, including the Star rating, is mechanically calculated and is based on historical information. The analysis assumes the stock will perform in the future as it has in the past. This is generally never true. Before buying or selling any stock you should do your own research and reach your own conclusion. See my Disclaimer for more information.

Full Disclosure: At the time of this writing, I was long in T (2.8% of my Dividend Growth Portfolio). See a list of all my dividend growth holdings here.

Related Articles:
- Digital Realty Trust, Inc. (DLR) Dividend Stock Analysis
- Verizon Communications Inc. (VZ) Dividend Stock Analysis
- Universal HealthRealty Income Trust (UHT) Dividend Stock Analysis
- AFLAC Incorporated (AFL) Dividend Stock Analysis
- More Stock Analysis

This article was written by Dividends4Life. If you enjoyed this article, please subscribe to my feed [RSS], or have future articles emailed to you [Email] or follow me on Twitter [Twitter].


Continue Reading »

Weekend Reading Links - February 5, 2012

For your weekend reading pleasure, the articles listed below contain some of the best dividend and value investing insights found on the web. They were written by various members of the Dividend Investing and Value Network over the past week:

Articles From DIV-Net Members

There are some really good articles here, please take time and read a few of them.


Continue Reading »

Johnson & Johnson Stock Analysis

Johnson & Johnson (JNJ) engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. This dividend aristocrat has paid uninterrupted dividends on its common stock since 1944 and increased payments to common shareholders every for 49 consecutive years. One of the largest shareholders is no other but Warren Buffett’s Berkshire Hathaway (BRK.B).

The company’s last dividend increase was in when the Board of Directors approved a 5.60% increase to 57 cents/share. Johnson & Johnson's major competitors include Abbott Laboratories (ABT), Bristol Myers Squibb (BMY) and Novartis (NVS).

Over the past decade this dividend growth stock has delivered an annualized total return of 3.50% to its shareholders.
The company has managed to deliver an 11.20% annual increase in EPS since 2001. Analysts expect Johnson & Johnson to earn $4.97 per share in 2011 and $5.23 per share in 2012. In comparison Johnson & Johnson earned $4.78 /share in 2010. The company has managed to consistently repurchase 1.40% of its outstanding shares on average in each year over the past decade.
The company’s return on equity has remained between 25% and 30% over the past decade.
Rather than focus on absolute values for this indicator, I generally want to see at least a stable return on equity over time.
The annual dividend payment has increased by 13% per year since 2002, which is higher than to the growth in EPS.
A 13% growth in distributions translates into the dividend payment doubling every five and a half years. If we look at historical data, going as far back as 1971 we see that Johnson & Johnson has actually managed to double its dividend every five years on average.

The dividend payout ratio has increased from 38% in 2001 to 44% in 2010. A lower payout is always a plus, since it leaves room for consistent dividend growth minimizing the impact of short-term fluctuations in earnings.
Currently Johnson & Johnson is attractively valued at 18.80 times earnings, has a sustainable dividend payout and yields 3.50%. I would consider adding to my position in the stock on any weakness in the stock price.

Full Disclosure: Long ABT and JNJ

Relevant Articles:


This article was written by Dividend Growth Investor. If you enjoyed this article, please subscribe to my feed [RSS], or have future articles emailed to you [Email] or follow me on Twitter [Twitter].


Continue Reading »

Trading Vs. Investing

There are many ways to make money in the stock market. There are a lot of pundits and followers of different strategies that would have you believe that they have a magic way to exploit the market for extraordinary profits with minimal work and time. Every time I read claims like that, I ask myself: "If it was so easy, and it makes you rich so fast, why are you busy writing articles instead of making millions of dollars?". Believe me, if someone has a "secret" that makes tons of money in a short period of time they're not going to share it with the world.

This leads me to the concept of stock trading. To me, stock trading is basically buying an equity with a short-term time horizon with the plan of selling it at a higher price in the near future. You are essentially trying to buy an asset with the hopes that you can quickly turn it and sell at a higher price to a sucker down the line. This is akin to gambling, in my view. There are day traders, who try to close buy-and-sell transactions in the same trading day. There are swing traders who try the "buy Y at $X and sell at $X+" game, and try and sell Y within days, weeks or even a month or two. Make no mistake, however, these are not investors. These are traders. They are trying to exploit an inefficient market by buying an equity at a distressed price and quickly make money on that equity. They try to repeat these transactions over and over again until they make significant profits. Traders are speculators, not investors.

There are a number of reasons that I don't actively trade. First, I can't predict the future. If I buy stock Y at $50, I have no idea if it will be worth $51 tomorrow or $48 tomorrow. Because of my inability to predict the future, I don't buy assets with the plan to quickly sell for a profit. There are analysts and money managers that try to follow trends and predict the way the stock market is going to react to certain news. Some of these money managers are paid millions of dollars to do this. Yet, I read countless articles about money managers that under-perform the general market. When you are actively trading in and out of positions you must remember that you are incurring taxes on capital gains and you are also incurring trading fees on transactions. I can see how taxes and fees could quickly erode any profits one would make with day trading or swing trading. In addition, you have to keep in mind that you are going to incur losses unless you're Nostradamus.

The main reason I don't trade, however, is that I'm an investor first and foremost. I believe the stock market is a wonderfully efficient platform for an average Joe like me to take my middle class income and invest with some of the biggest and best companies in the world. I like to invest with quality companies that have a history of rising earnings, revenues and dividends. I invest with companies that have an economic moat, economies of scale, large distribution networks, brand name products that people want and/or need. I invest with companies that can raise prices on their products at a percentage that exceeds inflation. I invest with companies like Johnson & Johnson (JNJ), Philip Morris International (PM) and Coca-Cola (KO) because I believe that they do an excellent job of making money and I believe that over the course of many, many years they will grow my investments many times over.

Stock trading is relying on your ability to forecast the future, stock trends, market efficiencies and your chances at selling your asset for a higher price in a short period of time. Many people have thought this was the true path to riches, and many people have failed. I'm not saying that day trading or swing trading can't make you money, but I don't believe it's the most efficient or reliable way of doing so. It's speculating. You could go to Las Vegas and double your money tomorrow. But how repeatable is that?

I like investing. I like putting my chips on major, multinational companies and letting them churn out profits over decades. They pay me dividends to invest with them, which I use to reinvest into my portfolio. Those reinvested dividends then accumulate additional shares, which then pay out larger dividends and this repeats itself over and over again. This is a reliable, repeatable and true way to build wealth over time. It's not speculating, it's not trading, it's not gambling and it won't make you rich over night. But, I believe for an investor who can spot value, is willing to be patient and who knows quality when they see it one can slowly build their wealth over time.

Keep in mind, however, that there is a difference between buy-and-hold and buy-and-monitor. I'm an investor of the latter type. I'm not saying that a long-term value-oriented dividend growth investor should never sell shares of a company. It's important to always monitor your investments and keep an eye out for any changes in a company's fundamentals. For instance, I spotted some changing fundamentals in one of my investments, Telefonica S.A. (TEF) (ADR) recently and I sold my shares because I believed the dividend was not sustainable. The dividend was cut a week later. It's important to keep a checklist of when to sell a dividend growth stock.

All in all, a speculator could make money trading in and out of the stock market. Trying to buy stocks at one price, just to sell in quick order at a higher price is simply not a game I'm willing to play. I have a full-time job and I have other things to attend to, and things I'd rather do than fret around my computer waiting for the right price to come. I'd rather invest my money for the long-term with excellent companies that are wonderfully proficient at making money and paying me dividends. The share prices of these companies naturally rise over time because these companies are efficient at increasing earnings and revenues, so their market cap naturally follows as more investors pile money into these companies' shares. I like investing in appreciating assets that rise in value over time, that also provide cash flow until the time comes to sell those assets, if ever.

What about you? Do you execute a trading strategy at all?

Full Disclosure: I'm long JNJ, PM, KO.

Thanks for reading.

This article was written by Dividend Mantra. If you enjoyed this article, please consider subscribing to my feed.


Continue Reading »

Virco Manufacturing Gets Smoked

Virco Manufacturing's market cap has fallen from $50 million a few months ago to about $24 million today, giving it a P/B ratio of under 0.6. The company manufactures and distributes desks, tables, chairs and other furniture for the education sector. It is the largest such manufacturer for the preschool through grade 12 market in the US, and offers a range of services from installation to classroom design capabilities.


Continue Reading »